Literature DB >> 14675621

The E7 oncoprotein of high-risk human papillomavirus type 16 enters the nucleus via a nonclassical Ran-dependent pathway.

Michael Angeline1, Eric Merle, Junona Moroianu.   

Abstract

E7, the major transforming protein of high-risk human papillomavirus (HPV), type 16, binds and inactivates the retinoblastoma protein (pRb), and the Rb-related proteins p107 and p130. HPV16 E7 is a nuclear protein lacking a classical basic nuclear localization signal. In this study we investigated the nuclear import of HPV16 E7 oncoprotein in digitonin-permeabilized HeLa cells. HPV16 E7 nuclear import was independent of pRb, as an E7(DeltaDLYC) variant defective in pRb binding was imported into the nuclei of digitonin-permeabilized cells as efficiently as wild-type E7 in the presence of exogenous cytosol. Interestingly, we discovered that HPV16 E7 is imported into the nuclei via a novel pathway different from those mediated by Kap alpha2beta1 heterodimers, Kap beta1, or Kap beta2. Nuclear accumulation of E7 required Ran and was not inhibited by the RanG19V-GTP variant, an inhibitor of Kap beta mediated import pathways. Together the data suggest that HPV16 E7 translocates through the nuclear pores via a nonclassical Ran-dependent pathway, independent of the main cytosolic Kap beta import receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675621     DOI: 10.1016/j.virol.2003.08.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study.

Authors:  Daniela Ehehalt; Barbara Lener; Haymo Pircher; Kerstin Dreier; Heiko Pfister; Andreas M Kaufmann; Sergio Frangini; Sigrun Ressler; Elisabeth Müller-Holzner; Markus Schmitt; Daniela Höfler; Ursula Rostek; Andreas Kaiser; Andreas Widschwendter; Werner Zwerschke; Pidder Jansen-Dürr
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

2.  Nuclear import of cutaneous beta genus HPV8 E7 oncoprotein is mediated by hydrophobic interactions between its zinc-binding domain and FG nucleoporins.

Authors:  Zeynep Onder; Junona Moroianu
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

3.  Nuclear import of bovine papillomavirus type 1 E1 protein is mediated by multiple alpha importins and is negatively regulated by phosphorylation near a nuclear localization signal.

Authors:  Xue-Lin Bian; Germán Rosas-Acosta; Yu-Chieh Wu; Van G Wilson
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

4.  Nuclear import of high risk HPV16 E7 oncoprotein is mediated by its zinc-binding domain via hydrophobic interactions with Nup62.

Authors:  Jeremy Eberhard; Zeynep Onder; Junona Moroianu
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

5.  Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein.

Authors:  Alixandra A Knapp; Patrick M McManus; Katy Bockstall; Junona Moroianu
Journal:  Virology       Date:  2008-11-08       Impact factor: 3.616

Review 6.  Human papillomavirus type 16 E5 protein as a therapeutic target.

Authors:  Sang-Woo Kim; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

7.  Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors.

Authors:  Sabine Schenck; Elke Kehm; Alberto L Epstein; Hanswalter Zentgraf; Martin Müller; Charles W Knopf
Journal:  Virus Genes       Date:  2008-06-12       Impact factor: 2.332

Review 8.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

9.  Characterization of the transport signals that mediate the nucleocytoplasmic traffic of low risk HPV11 E7.

Authors:  Courtney H McKee; Zeynep Onder; Aditya Ashok; Rebeca Cardoso; Junona Moroianu
Journal:  Virology       Date:  2013-05-29       Impact factor: 3.616

10.  Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes.

Authors:  Christine L Nguyen; Karl Münger
Journal:  Virology       Date:  2008-08-21       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.